Tissue plasminogen activator protects hippocampal neurons from oxygen-glucose deprivation injury - PubMed (original) (raw)

Tissue plasminogen activator protects hippocampal neurons from oxygen-glucose deprivation injury

M P Flavin et al. J Neurosci Res. 2001.

Abstract

We have previously shown that tissue plasminogen activator (tPA) participates in the neurotoxicity of microglial conditioned medium (MgCM). Killing of hippocampal neurons by MgCM was prevented by both plasminogen activator inhibitor-1 (PAI-1) and anti-tPA antibody. An N-methyl-D-aspartate (NMDA) receptor blocker protected neurons from MgCM, suggesting that this subtype of glutamate receptor is involved. Whereas glutamate receptor-mediated events are important in cerebral ischemia and tPA has previously been shown to enhance excitotoxicity in hippocampus, we hypothesized that tPA would exaggerate oxygen glucose deprivation (OGD) injury in cultures of hippocampal neurons. Dissociated rat hippocampal cells were grown under conditions designed to optimize neuronal growth while minimizing glial replication. At 7--10 days, cultures were subjected to OGD for 2.5 hr. Recombinant human tPA (1,000 IU) was added immediately after OGD. Viability was assessed 24 hr later. Viable, apoptotic, and necrotic cells were classified and quantified based on staining patterns of acridine orange and ethidium bromide under fluorescence microscopy. tPA alone did not alter neuronal integrity. OGD produced significant neuronal death (viability reduced by 45%, P < 0.001). tPA completely protected OGD-exposed cultures. Potential mechanisms of tPA protection were explored. Whereas tPA antibody abolished the protective effect of tPA, its proteolytic inhibitor PAI-1 did not alter the effect. The effect of tPA was tested in separate free radical and excitatory amino acid insults. It did not protect neurons from hydrogen peroxide (1 microM), S-nitro-acetylpenicillamine (10 microM), glutamate (50 microM), or NMDA (10 microM) damage but significantly attenuated injury caused by 250 microM kainate. We conclude that tPA is capable of protecting hippocampal neurons from OGD by a nonproteolytic action. The mechanism of protection was not defined, although attenuation of AMPA/kainate glutamate receptors may play a role.

PubMed Disclaimer

Cited by

Stressed neurons protect themselves by a tissue-type plasminogen activator-mediated EGFR-dependent mechanism.
Lemarchand E, Maubert E, Haelewyn B, Ali C, Rubio M, Vivien D. Lemarchand E, et al. Cell Death Differ. 2016 Jan;23(1):123-31. doi: 10.1038/cdd.2015.76. Epub 2015 Jun 12. Cell Death Differ. 2016. PMID: 26068590 Free PMC article.
Plasminogen Activators in Neurovascular and Neurodegenerative Disorders.
Yepes M, Woo Y, Martin-Jimenez C. Yepes M, et al. Int J Mol Sci. 2021 Apr 22;22(9):4380. doi: 10.3390/ijms22094380. Int J Mol Sci. 2021. PMID: 33922229 Free PMC article. Review.
Targeted tPA overexpression in denervated spinal motor neurons promotes stroke recovery in mice.
Gan X, Chopp M, Xin H, Wang F, Golembieski W, Lu M, He L, Liu Z. Gan X, et al. J Cereb Blood Flow Metab. 2021 Jan;41(1):92-104. doi: 10.1177/0271678X20901686. Epub 2020 Jan 27. J Cereb Blood Flow Metab. 2021. PMID: 31987011 Free PMC article.
Hypoxic preconditioning protects against ischemic brain injury.
Sharp FR, Ran R, Lu A, Tang Y, Strauss KI, Glass T, Ardizzone T, Bernaudin M. Sharp FR, et al. NeuroRx. 2004 Jan;1(1):26-35. doi: 10.1602/neurorx.1.1.26. NeuroRx. 2004. PMID: 15717005 Free PMC article. Review.
Tissue-type plasminogen activator exerts EGF-like chemokinetic effects on oligodendrocytes in white matter (re)myelination.
Leonetti C, Macrez R, Pruvost M, Hommet Y, Bronsard J, Fournier A, Perrigault M, Machin I, Vivien D, Clemente D, De Castro F, Maubert E, Docagne F. Leonetti C, et al. Mol Neurodegener. 2017 Feb 23;12(1):20. doi: 10.1186/s13024-017-0160-5. Mol Neurodegener. 2017. PMID: 28231842 Free PMC article.

Tissue plasminogen activator protects hippocampal neurons from oxygen-glucose deprivation injury - PubMed (original) (raw)